Image Title
At a time when the world is watching and expecting lightning fast results from drug development for SARS-COV-2 therapies, ACD/Labs' Joe DiMartino reflects on the impediments drug development teams face in releasing an antiviral drug quickly while keeping safety and quality at the forefront.
Read Blog
Over the last few months we have been working with many R&D organizations to help support remote working and physical/social distancing. As well as providing software training sessions and complimentary license expansions, we also created a guidance to help scientists maintain productivity.
Download the Whitepaper
Image Title
Image Title
The pandemic has forced changes to the working environment for many. While some organizations are shut down, others are adapting to shift-work and trying out working from home. We’re interested to learn how its impacting you. Take a short survey to share your experience and opinions. We’ll share the results at a later date.
Take the Survey
Join ACD/Labs' James Hogbin as he draws upon 41 years of method-development experience to explain the distinction between separations and analytical methods, and how to plan for the latter.
Register Now
Download the Whitepaper
Access Webinars
By popular demand we have expanded the software available for purchase on our web store. If you’re looking to add chemical nomenclature to your software toolset, simply login, purchase, and download ACD/Name (Chemist Version), today.
Buy Now
Learn how to get more from your ACD/Labs software by joining our Power Lessons. These bi-weekly webinars focus on different software applications covering best practices, tips and tricks, and most importantly we answer your questions.
Register Now
Image Title